HSP10, HSP60, and HSP70 overexpression associates with PD-L1 upregulation and adverse outcomes in on-small cell lung cancer
Pathology - Research and Practice · 2026
DOI: 10.1016/j.prp.2026.156587 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathology - Research and Practice, 2026. Verfasst von Yuling Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China. Hauptthemen laut MEDLINE: Lung Neoplasms, HSP70 Heat-Shock Proteins, Carcinoma, Non-Small-Cell Lung, Chaperonin 60. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Natural Science Foundation of Hunan Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: HSP10, HSP60, and HSP70, members of the heat shock protein (HSP) family, are cytoprotective stress-response chaperones involved in protein homeostasis and critical pathways, including inflammation. Aberrant expression of these proteins has been observed in many tumors and is associated with patients' prognosis. Immunotherapy with checkpoint inhibitors, particularly those targeting the Programmed Death-1 (PD-1)/ Programmed Death Ligand 1 (PD-L1) axis, has emerged as a highly promising therapeutic approach for non-small cell lung cancer (NSCLC). METHODS: Public databases and bioinformatics analyses were employed to investigate the relationship between HSP10, HSP60, HSP70 and PD-L1. This predicted association was further validated using immunohistochemistry (IHC) on tissue microarrays (TMAs) comprising 43 cases of adjacent non-cancerous lung tissue (Non-CLT) and 433 cases of surgically resected NSCLC (including 294 cases of adenocarcinoma and 139 cases of squamous cell carcinoma). Additionally, the correlation between the expression of these HSPs and the clinicopathological features of NSCLC was examined. RESULTS: Pan-cancer analysis revealed significantly elevated levels of HSP10, HSP60 and HSP70 in most cancers compared to normal tissues. In NSCLC, these HSPs showed markedly higher expression at both mRNA and protein levels than in adjacent Non-CLT. Patients with advanced clinical stage or lymph node metastasis (LNM) exhibited higher HSP60 and HSP70 expression than those with early-stage disease or no LNM. Notably, all three HSPs demonstrated positive correlations with both PD-L1 expression (mRNA and protein levels) but negative correlations with the infiltration of most immune cells. Moreover, elevated these three HSPs expression was associated with significantly shorter overall survival (OS) time in NSCLC patients. Multivariate analysis confirmed that overexpression of HSP10, HSP60, and HSP70 was identified as a poor prognostic factor for NSCLC. CONCLUSIONS: High expression of HSP10, HSP60, and HSP70 correlates with PD-L1 levels may serve as novel biomarkers for poor prognosis in NSCLC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China.
- Department of Pathology, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China. Electronic address: wenqiuyuan@csu.edu.cn.
Förderung
- Natural Science Foundation of Hunan Province
- National Natural Science Foundation of China
Zitieren
APA
Zhang, Y., Zhou, Y., Yang, Y., Wang, Z., Chen, Z., Fan, S., Zang, H., & Wen, Q. (2026). HSP10, HSP60, and HSP70 overexpression associates with PD-L1 upregulation and adverse outcomes in on-small cell lung cancer. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2026.156587
Vancouver
Zhang Y, Zhou Y, Yang Y, Wang Z, Chen Z, Fan S, et al. HSP10, HSP60, and HSP70 overexpression associates with PD-L1 upregulation and adverse outcomes in on-small cell lung cancer. Pathology - Research and Practice. 2026. doi:10.1016/j.prp.2026.156587
BibTeX
@article{Zhang2026,
author = {Zhang, Yuling and Zhou, Ying and Yang, Yang and Wang, Ziyi and Chen, Zihao and Fan, Songqing and Zang, Hongjing and Wen, Qiuyuan},
title = {HSP10, HSP60, and HSP70 overexpression associates with PD-L1 upregulation and adverse outcomes in on-small cell lung cancer},
journal = {Pathology - Research and Practice},
year = {2026},
doi = {10.1016/j.prp.2026.156587}
}
EUVIMED